Ownership history in BARCLAYS PLC · 28 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,767 | -3,851 | -58.2% | 0.00% | $2K | $8.70 |
| 2025 Q2 | REDUCED | 6,618 | -109,668 | -94.3% | 0.00% | $5K | $7.10 |
| 2025 Q1 | REDUCED | 116,286 | -42,528 | -26.8% | 0.00% | $76K | $6.50 |
| 2024 Q4 | REDUCED | 158,814 | -114,205 | -41.8% | 0.00% | $293K | $18.40 |
As of 2025 Q4 — sorted by position size